Pharmacokinetic variability and exposures of fluconazole, anidulafungin and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
1 Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
2 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
3 Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia
4 Royal Brisbane and Women’s Hospital, Brisbane, Australia
5 School of Medicine, Hacettepe University, Ankara, Turkey
6 Azienda Ospedaliera Universitaria Santa Maria della Misericordia, Udine, Italy
7 Ghent University Hospital, Ghent, Belgium
8 Helsinki University Central Hospital, Helsinki, Finland
9 Attikon University Hospital, Athens, Greece
10 Hospital Nord, Marseille, France
11 AzuRea Group, Antibes, France
12 Centre Hospitalier Universitaire Bichat-Claude Bernard, AP-HP, Université Paris VII, Paris, France
13 CIBERES, Vall d’Hebron Institute of Research, Universitat Autonoma de Barcelona, Barcelona, Spain
14 St George’s Healthcare NHS Trust and St George’s University of London, London, England